Blood Immunophenotyping in Staging of Indolent B-cell Lymphomas V1.0

Phase III, Multicentre, Randomised Study of Fludarabine/Cyclophosphamide Combination With or Without Rituximab in Patients With Untreated Mantle Cell Lymphoma

NCT00641095 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Study of the Kinetics of Lymphoid Cells in Patients With Monoclonal B-cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL), Mantle Cell Lymphoma (MCL) and Healthy Volunteers

NCT01117142 ·Status: COMPLETED

Study for Newly Diagnosed Follicular Lymphoma Patients With a Large Tumor Burden

NCT00136552 ·Status: COMPLETED ·Phase: PHASE3

Study to Assess Clinical Characteristics and Outcome of Patients with Marginal Zone Lymphomas

NCT06806488 ·Status: RECRUITING

Minimal Residual Disease in Peripheral T-cell Lymphoma

NCT03297697 ·Status: COMPLETED

Induction Chemotherapy (R-CHOP Vs. R-FC) Followed by Interferon Maintenance Versus Rituximab Maintenance in MCL

NCT00209209 ·Status: UNKNOWN ·Phase: PHASE3

Signatures of Response and Resistance to Mosunetuzomab in Follicular Lymphomas (FL)

NCT05529524 ·Status: COMPLETED

Randomised Trial in Waldenstrom's Macroglobulinaemia

NCT01592981 ·Status: COMPLETED ·Phase: PHASE2

Study Comparing Inotuzumab Ozogamicin In Combination With Rituximab Versus Defined Investigator's Choice In Follicular Non-Hodgkin's Lymphoma (NHL)

NCT00562965 ·Status: TERMINATED ·Phase: PHASE3

This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma

NCT07121946 ·Status: RECRUITING ·Phase: PHASE1

Identification Predictive Markers of Immunochemotherapy Response to the Primary Cutaneous Diffuse Large B Cell Lymphoma

NCT04183569 ·Status: UNKNOWN

Bortezomib and Rituximab in Treating Patients With Mantle Cell Lymphoma Who Have Previously Undergone Stem Cell Transplantation

NCT01267812 ·Status: COMPLETED ·Phase: PHASE2

A Clinico-Pathologic Study of Primary Mediastinal B-Cell Lymphoma

NCT00944567 ·Status: COMPLETED

Relmacabtagene Autoleucel as First-Line Therapy for High-Risk Large B-Cell Lymphoma

NCT05590221 ·Status: RECRUITING ·Phase: PHASE2

Integrated Molecular and Clinical Profiling to Improve Disease Characterization and Outcome Prediction in Nodal Marginal Zone Lymphoma

NCT05700149 ·Status: RECRUITING

Study of Epigenetic and Inflammatory Markers of Accelerated Biological Ageing in the Follow up of Patients With Hodgkin's Lymphoma

NCT06761274 ·Status: RECRUITING ·Phase: NA

Brief Chemoimmunotherapy With R+B+M Followed by R in Elderly Patients Advanced Stage Untreated Follicular Lymphoma

NCT01523860 ·Status: COMPLETED ·Phase: PHASE2

B-cell Chronic Lymphoid Malignancies Markers

NCT04952974 ·Status: UNKNOWN

A Study of Atezolizumab in Combination With Either Obinutuzumab Plus Bendamustine or Obinutuzumab Plus (+) Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) in Participants With Follicular Lymphoma (FL) or Rituximab + CHOP in Participants With Diffuse Large B-Cell Lymphoma (DLBCL)

NCT02596971 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study of Prognostic Factors in Adult Lymphoblastic Lymphoma

NCT03571997 ·Status: UNKNOWN

Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry

NCT01110733 ·Status: COMPLETED

A Study of Reduced Dose Radiation Therapy for People With B-Cell Lymphomas

NCT07029217 ·Status: RECRUITING ·Phase: PHASE3

Flow Cytometry for the Study of T-Cell Populations in Hemophagocytic Lymphohistiocytosis Associated With Lymphomas

NCT06585124 ·Status: RECRUITING

Mixed Molecular Clinical Index (MMCI) in Diffuse Large B-cell Lymphoma (DLBCL)

NCT04300101 ·Status: RECRUITING

MELT - MRI Evaluation of Lymphoma Treatment

NCT01459224 ·Status: COMPLETED